Article ID Journal Published Year Pages File Type
6174435 European Journal of Obstetrics & Gynecology and Reproductive Biology 2012 5 Pages PDF
Abstract
Of patients with LABCC, those with non-SCC tumors ≥8 cm in size were at high risk for early central-only recurrence after cisplatin-based chemoradiation, and represent the subset of patients for whom AHR is beneficial.
Related Topics
Health Sciences Medicine and Dentistry Obstetrics, Gynecology and Women's Health
Authors
, , , , , , ,